Literature DB >> 6501087

Lysinomicin, a new aminoglycoside antibiotic. II. Structure and stereochemistry.

P Kurath, W Rosenbrook, D A Dunnigan, J B McAlpine, R S Egan, R S Stanaszek, M Cirovic, S L Mueller, W H Washburn.   

Abstract

The structure of lysinomicin, a new aminocyclitol antibiotic, was established as 3-epi-2'-N-(L-beta-lysyl)-4',5'-didehydro-6'-de-C-methylfortimi cin B (1) on the basis of spectral evidence and chemical degradation of the antibiotic. In the course of the degradation of 1, three additional compounds with interesting biological properties were obtained: 3-epi-2'-N-(L-beta-lysyl)-6'-de-C-methylfortimicin B (4), 3-epi-4',5'-didehydro-6'-de-C-methylfortimicin B (6) and 3-epi-6'-de-C-methylfortimicin B (7).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6501087     DOI: 10.7164/antibiotics.37.1130

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  2 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  The pseudodisaccharides: a novel class of group I intron splicing inhibitors.

Authors:  J Rogers; J Davies
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.